MedTrace Logo

Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China

NCT06099028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22500

Last updated 2024-01-23

No results posted yet for this study

Summary

This is a retrospective, researcher-initiated, database-based study that will retrospectively observe the treatment and medication patterns of about 22,500 patients with heart failure from 25 heart failure centers and 25 non-heart failure centers in the database of heart failure center. The proportion of patients with heart failure treatment drugs reaching the target dose recommended in the guidelines and discontinuation rate will be observed at 1 month, 3 months and 12 months follow up time point. The purpose of this study is to illustrate the current HF treatment status in HF center hospitals and non-HF center hospitals, which may provide insights for improving the clinical practice of heart failure treatment in China, and promote the standardization of heart failure treatment in China.

Conditions

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • China Cardiovascular Association

    collaborator OTHER

  • AstraZeneca

    collaborator INDUSTRY

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • Huo Yong, MD. · Peking University First Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06099028 on ClinicalTrials.gov